SE9603468D0 - New compounds - Google Patents

New compounds

Info

Publication number
SE9603468D0
SE9603468D0 SE9603468A SE9603468A SE9603468D0 SE 9603468 D0 SE9603468 D0 SE 9603468D0 SE 9603468 A SE9603468 A SE 9603468A SE 9603468 A SE9603468 A SE 9603468A SE 9603468 D0 SE9603468 D0 SE 9603468D0
Authority
SE
Sweden
Prior art keywords
variable
amino acid
formula
description
peptides
Prior art date
Application number
SE9603468A
Other languages
English (en)
Swedish (sv)
Inventor
Haakan Bergstrand
Tomas Eriksson
Magnus Lindvall
Bengt Saernstrand
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9603468A priority Critical patent/SE9603468D0/xx
Publication of SE9603468D0 publication Critical patent/SE9603468D0/xx
Priority to AU44063/97A priority patent/AU4406397A/en
Priority to PCT/SE1997/001554 priority patent/WO1998012219A1/en
Priority to ZA9708472A priority patent/ZA978472B/xx
Priority to ARP970104371A priority patent/AR009807A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE9603468A 1996-09-23 1996-09-23 New compounds SE9603468D0 (sv)

Priority Applications (5)

Application Number Priority Date Filing Date Title
SE9603468A SE9603468D0 (sv) 1996-09-23 1996-09-23 New compounds
AU44063/97A AU4406397A (en) 1996-09-23 1997-09-15 Methionine, penicillamine and cysteine-analogue containing peptides having immunomodulating activity
PCT/SE1997/001554 WO1998012219A1 (en) 1996-09-23 1997-09-15 Methionine, penicillamine and cysteine-analogue containing peptides having immunomodulating activity
ZA9708472A ZA978472B (en) 1996-09-23 1997-09-19 Cysteine analogue containing peptides.
ARP970104371A AR009807A1 (es) 1996-09-23 1997-09-23 Peptidos que contienen analogos de cisteina.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9603468A SE9603468D0 (sv) 1996-09-23 1996-09-23 New compounds

Publications (1)

Publication Number Publication Date
SE9603468D0 true SE9603468D0 (sv) 1996-09-23

Family

ID=20403990

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9603468A SE9603468D0 (sv) 1996-09-23 1996-09-23 New compounds

Country Status (5)

Country Link
AR (1) AR009807A1 (xx)
AU (1) AU4406397A (xx)
SE (1) SE9603468D0 (xx)
WO (1) WO1998012219A1 (xx)
ZA (1) ZA978472B (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2452417C (en) * 2001-07-13 2013-08-20 Pepharm R & D Limited Compositions comprising the biologicially active peptide ysl
CN1210292C (zh) 2001-07-13 2005-07-13 一泰医药研究（深圳）有限公司 序列号22的生物活性肽
CN101501062B (zh) 2005-07-26 2012-07-18 康哲医药研究(深圳)有限公司 新型生物活性肽及其新用途
JP5399238B2 (ja) * 2006-06-14 2014-01-29 サントル、ナショナール、ド、ラ、ルシェルシュ、シアンティフィク、（セーエヌエルエス） 新規な担持された酸化反応物、それらの製造方法、およびその使用
CA2954934C (en) 2014-06-30 2023-09-26 Glykos Finland Oy Drug derivative and conjugates
US9988434B2 (en) * 2014-09-12 2018-06-05 Wisconsin Alumni Research Foundation Optimal interstrand bridge for collagen mimics
RS63143B1 (sr) 2016-06-01 2022-05-31 Athira Pharma Inc Jedinjenja
CN108484640B (zh) * 2018-05-22 2020-09-15 南京华威医药科技集团有限公司 一种抗肿瘤的细胞凋亡蛋白抑制剂

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0271041A3 (en) * 1986-12-10 1990-04-11 Abbott Laboratories Atrial peptide derivatives
AU1366088A (en) * 1987-01-28 1988-08-24 Ortho Pharmaceutical Corporation Immunosuppressive peptides and methods of use
DE3841759A1 (de) * 1988-12-12 1990-06-13 Basf Ag Neue tnf-peptide
CA2045578A1 (en) * 1989-01-31 1990-08-01 Megumi Kawai Anaphylatoxin-receptor ligands
US5494672A (en) * 1989-04-28 1996-02-27 S.P.I. Synthetic Peptides Incorporated Pseudomonas peptide composition and method
US5137873A (en) * 1990-07-27 1992-08-11 The Children's Medical Center Corporation Substance p and tachykinin agonists for treatment of alzheimer's disease
WO1993024136A1 (en) * 1991-01-17 1993-12-09 Terman David S Tumor killing effects of enterotoxins, superantigens, and related compounds
EP0629213B1 (en) * 1992-03-07 1996-10-23 Morinaga Milk Industry Co., Ltd. Use of an immunostimulatory agent
US6696061B1 (en) * 1992-08-11 2004-02-24 President And Fellows Of Harvard College Immunomodulatory peptides
CA2144180A1 (en) * 1992-09-08 1994-03-17 George A. Heavner Peptide inhibitors of cellular adhesion
AUPM446594A0 (en) * 1994-03-16 1994-04-14 Csl Limited Cytotoxic t-cell epitopes identified within epstein-barr virus
EP0756629A1 (en) * 1994-04-08 1997-02-05 Immunologic Pharmaceutical Corporation Pharmaceutical formulations for treating japanese cedar pollen allergy
RU2218348C2 (ru) * 1994-07-05 2003-12-10 Стено Рисерч Груп А/С Полипептид с il-10 подобными свойствами (варианты), конъюгат полипептида, фармацевтическая композиция, способ модуляции иммунного ответа у млекопитающего
SE9403526D0 (sv) * 1994-10-14 1994-10-14 Astra Ab New Peptides
EP0923604A1 (en) * 1996-04-12 1999-06-23 Astra Aktiebolag Cysteine-containing or methioine-containing peptides with immunomodulatory effects

Also Published As

Publication number Publication date
ZA978472B (en) 1998-03-23
AU4406397A (en) 1998-04-14
AR009807A1 (es) 2000-05-03
WO1998012219A1 (en) 1998-03-26

Similar Documents

Publication Publication Date Title
DE69126568D1 (de) Neues physiologisch aktives Schweinepeptid (CNP-53)
NO920252L (no) T celle-reseptor peptider som terapeutiske midler for autoimmune og maligne sykdommer
DE69535963D1 (de) LHRH antagonistische Peptide
EP2327712A3 (en) Treatment of autoimmune conditions with copolymer 1 and related copolymers and peptides
DK0966297T4 (da) Regulering af gastrointestinal motilitet
DK0643726T3 (da) Peptider af humant p53-protein til anvendelse i sammensætninger, som inducerer humant T-celle-respons, og humane p53-protei
ATE260658T1 (de) Pharmazeutische zubereitungen zur verminderung von atmungsdepressionen
TR199802534T2 (xx) Leptin (OB Protein) fragmanlar�
KR910700062A (ko) 마가이닌 펩타이드의 결실 동족체
RU94036776A (ru) Домен ингибитора протеазы, днк, вектор, клетка, способ получения ингибитора протеазы, фармацевтическая композиция, применение домена ингибитора протеазы
SE9603468D0 (sv) New compounds
DE69728914D1 (de) Pharmazeutische Zusammensetzung gegen durch Papillomaviren verursachte Tumoren und Infektionen
NO934320D0 (no) T celle reseptor peptider som terapeutiske midler for immun-relaterte sykdommer
IL91317A0 (en) New antibiotic,mersacidin,a process for the preparation thereof and the use thereof as a pharmaceutical
SE9501067D0 (sv) New peptides
SE9603461D0 (sv) New compounds
DE69613395D1 (de) Schwefelenthaltende di-ter-butylphenol-verbindungen brauchbar als entzündungshemmende mittel
DK1154786T3 (da) Sammensætninger til modulering af mucus-sekretionen
FI971427A0 (fi) Peptidit ja niitä sisältävät farmaseuttiset koostumukset
SE9603466D0 (sv) New compounds
ATE356209T1 (de) Mutanten des thyroid-stimulierenden hormons
SE9603462D0 (sv) New compounds
ATE42308T1 (de) Pharmakologisch aktive peptide.
ATE342716T1 (de) Verwendung von carboxy verbindungen wie 2(4- acetoxyphenyl)-2-chloro-n-methyl-ethylammonium chlorid als entzündungshemmende mittel
SE9603463D0 (sv) New compounds